1. Aretha Franklin, Who Had Diabetes, Passes Away

    The Queen of Soul was private about her diabetes and her health concerns. We gather what she disclosed about her health over the years. -Craig Idlebrook/GluCraig Aretha Franklin, the Queen of Soul, has died from pancreatic cancer. Reviewing published reports about her health in the wake of her passing, it becomes clear she was as […]

    Read More
  1. Xeris Asks FDA to Approve Ready-to-Use Glucagon Pen

    If approved, it would become the first room temperature-stable liquid glucagon on the market. -Craig Idlebrook/GluCraig Xeris Pharmaceuticals announced it has submitted a ready-to-use glucagon pen to the FDA for approval. Earlier this year, the drugmaker announced it had successfully completed two Phase III studies and a separate usability study showing that its Glucagon Rescue […]

    Read More
  2. A Needle-less Closed-Loop Insulin Pump System?

    A diabetes tech company in India wants to create a low-cost automated pump system that uses electric pulses to open up skin pores wide enough to absorb insulin. Satya Tapas (left) and Nitin Saluja (right) of SciDogma Research By Shahd Husein/GluShahd Imagine a wristwatch that pulses insulin through the skin without a needle pricking the […]

    Read More
  3. Tidepool Now Compatible with Medtronic 630G, 640G, and 670G Pumps

    The move now gives Medtronic pump users an alternative to Medtronic’s CareLink data platform. -Craig Idlebrook/GluCraig Medtronic pump users will have an expanded opportunity to utilize the Tidepool platform to access and share data from their insulin pumps. Tidepool is now compatible with Medtronic 630G, 640G, and 670G pumps, according to Christopher Snider, Tidepool community […]

    Read More
  1. How All-Payer Healthcare Might Bring Down the Price of Insulin

    We examine the difference between single-payer healthcare and an all-payer system, which actually has been tried in some states. –GluColleenG In a recent Glu Question of the Day poll, some commenters suggested collective bargaining power is needed to bring down the high price of insulin. Many associate this collective bargaining power with single-payer healthcare (sometimes […]

    Read More
  2. 5 Strange-But-True Facts About Diabetes Throughout History

    Take a look at how diabetes was treated and diagnosed throughout history. -Linda Crasco/Linda C Insulin therapy may be less than a century old, but the history of diabetes stretches back millennia. Here are five historical factoids on diabetes through the ages:   Want more type 1 diabetes-related news stories, and the chance to help […]

    Read More
  3. Hypo-RESOLVE: A Global Push to Define Hypoglycemia

    For perhaps the first time ever, researchers are trying to standardize the definition of hypoglycemia and its aftereffects. T1D Exchange is providing important biological samples and data to help with the effort. By Shahd Husein/GluShahd Imagine three doctors locked in a dark room with an elephant. One, grasping the trunk, decides it’s a fire hose. The […]

    Read More
  4. Lilly Asks FDA to Approve Nasal Glucagon for Use With People with Type 1 Diabetes

    If approved, it could have the potential to reshape how severe hypoglycemia is treated. -Craig Idlebrook/GluCraig UPDATE – 7/25/2018 – Lilly clarifies that they are asking for the FDA and the EMA to approve this drug for both people with both type 1 diabetes and people with type 2 diabetes to use.  Nasal glucagon is going […]

    Read More
  5. Increased CGM Use Didn’t Stop Rise in HbA1C Levels: Study

    But CGM users saw less of a rise in levels than non-CGM users. We sum up this and four other studies from the T1D Exchange clinic registry that were accepted for the American Diabetes Association 78th Annual Scientific Sessions. By Craig Idlebrook/GluCraig Recently, 10 abstracts from researchers with the T1D Exchange clinic registry were accepted […]

    Read More
  6. T1D Exchange Research Roundup: Half-Unit Insulin Pens Reduced Anxiety

    Read the results of five studies from T1D Exchange’s Patient-Centered Research team. All five abstracts were posters at the ADA 78th Annual Scientific Sessions in Orlando. By Shahd Husein/GluShahd In June, researchers, industry representatives, and stakeholders gathered at the American Diabetes Association’s 78th Annual Scientific Sessions in Orlando, Florida to share the latest in diabetes prevention, […]

    Read More